Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Vomiting 2Nausea 2Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Pancreatic Neoplasms 1Liver Neoplasms 1Gallbladder Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1Brain Neoplasms 1Bile Duct Neoplasms 1Appendiceal Neoplasms 1Anus Neoplasms 1

Interventions

Fluorouracil 4Radiotherapy 3Mitomycin 3Surveys and Questionnaires 2Observation 2Cisplatin 2tempol 1rocakinogene sifuplasmid 1pembrolizumab 1fludarabine 1enzalutamide 1durvalumab 1abiraterone 1Vorinostat 1VGX-3100 1Therapeutics 1Taxes 1Specimen Handling 1Psychiatric Rehabilitation 1Palonosetron 1Paclitaxel 1Nivolumab 1Magnetic Resonance Spectroscopy 1MEDI0457 1Ipilimumab 1Interviews as Topic 1Interleukin-2 1Immunoglobulin G 1Genetic Testing 1Disulfides 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Anus Neoplasms × Palonosetron × Clear all
NCT00903396 2017-11-24

Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer

Alliance for Clinical Trials in Oncology

Phase 2 Terminated
7 enrolled 1 chart
Gastrointestinal

Anus Neoplasms, Appendiceal Neoplasms, Bile Duct Neoplasms, Colonic Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Nausea, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Vomiting, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡